Zdrowie i gospodarka · 04/11/2013
FDA Clears INVEGA Extended-Release Tablet for Approval
The FDA has determined that INVEGA (paliperidone) extended-release tablet, 12 mg, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of the medication through abbreviated new drug applications.